- Home
- KPLT vs LVTX Comparison
KPLT vs LVTX Comparison
Compare KPLT & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- LVTX
- Stock Information
- Founded
- KPLT 2012
- LVTX 2016
- Country
- KPLT United States
- LVTX Netherlands
- Employees
- KPLT N/A
- LVTX N/A
- Industry
- KPLT Diversified Commercial Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- KPLT Consumer Discretionary
- LVTX Health Care
- Exchange
- KPLT Nasdaq
- LVTX Nasdaq
- Market Cap
- KPLT 35.6M
- LVTX 33.9M
- IPO Year
- KPLT N/A
- LVTX 2021
- Fundamental
- Price
- KPLT N/A
- LVTX N/A
- Analyst Decision
- KPLT Hold
- LVTX Hold
- Analyst Count
- KPLT 2
- LVTX 3
- Target Price
- KPLT $12.00
- LVTX $1.75
- AVG Volume (30 Days)
- KPLT 26.3K
- LVTX 12.3K
- Earning Date
- KPLT 08-13-2025
- LVTX 08-19-2025
- Dividend Yield
- KPLT N/A
- LVTX N/A
- EPS Growth
- KPLT N/A
- LVTX N/A
- EPS
- KPLT N/A
- LVTX N/A
- Revenue
- KPLT $254,079,000.00
- LVTX $4,990,000.00
- Revenue This Year
- KPLT $22.26
- LVTX N/A
- Revenue Next Year
- KPLT $11.03
- LVTX N/A
- P/E Ratio
- KPLT N/A
- LVTX N/A
- Revenue Growth
- KPLT 9.72
- LVTX N/A
- 52 Week Low
- KPLT $5.08
- LVTX $0.85
- 52 Week High
- KPLT $21.88
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- KPLT 44.48
- LVTX 52.45
- Support Level
- KPLT $7.37
- LVTX $1.27
- Resistance Level
- KPLT $8.44
- LVTX $1.38
- Average True Range (ATR)
- KPLT 0.77
- LVTX 0.04
- MACD
- KPLT -0.06
- LVTX -0.00
- Stochastic Oscillator
- KPLT 21.86
- LVTX 44.64
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.